These effects were associated with a limited capacity of the gliomas cells to contribute to the pool of pericytes in Tau-high tumors, which results in a reduced number of dilated BVs and a less efficient fueling of tumor growth [11]. The gene discussed is MAPT; the disease is neoplasm.